EBOS Group Limited/Announcement
EBOS Group Limited logo

SPH Notice – Sybos Holdings Pte Limited

Substantial Holder Notice20 November 2019EBOHealthcare

Disclosure of movement of 1% or more in substantial holding
or change in nature of relevant interest, or both

Section 277 and 278, Financial Markets Conduct Act 2013

To: NZX Limited

and

To: EBOS Group Limited ("EBOS")

Relevant event being disclosed: Movement of 1% or more in substantial holding

Date of relevant event: 21 November 2019

Date this disclosure made: 21 November 2019

Date last disclosure made: 19 November 2019

Substantial product holder(s) giving disclosure

Full name(s): Sybos Holdings Pte Limited ("Sybos")

Summary of substantial holding

Class of quoted voting products: Ordinary shares in EBOS (NZX, ASX: EBO)

Summary for Sybos

For this disclosure, —

(a) total number held in class: 45,525,721

(b) total in class: 162,122,680

(c) total percentage held in class: 28.081%

For last disclosure,—

(a) total number held in class: 60,525,721

(b) total in class: 162,122,680

(c) total percentage held in class: 37.333%

Details of transactions and events giving rise to relevant event

Details of the transactions or other events requiring disclosure:

On 18 November 2019, Sybos entered into a block trade agreement (the "Agreement")

with UBS New Zealand Limited ("UBS") under which Sybos appointed UBS to manage and

underwrite the sale of 15,000,000 ordinary shares in EBOS currently held by Sybos for

NZ$22.50 per share (or NZ$337,500,000 in aggregate). A copy of the Agreement was

attached to Sybos's substantial product holder notice to the NZX dated 19 November 2019.

Settlement of this sale has now occurred.

Details after relevant event
Details for Sybos

Nature of relevant interest(s): Registered holder and beneficial owner of securities

For that relevant interest,—

(a) number held in class: 45,525,721

(b) percentage held in class: 28.081%

(c) current registered holder(s): Sybos

(d) registered holder(s) once transfers are registered: Unknown

Additional information

Address(es) of substantial product holder(s): C/- Russell McVeagh, Level 30 Vero Centre, 48

Shortland Street, Auckland 1010, New Zealand

Contact details:


Name: David Raudkivi, Russell McVeagh

Phone: 09 367 8000

Email: david.raudkivi@russellmcveagh.com

Name of any other person believed to have given, or believed to be required to give, a

disclosure under the Financial Markets Conduct Act 2013 in relation to the financial

products to which this disclosure relates: UBS New Zealand Limited

Certification

I, Marshall Byres, director of Sybos, certify that, to the best of my knowledge and belief, the

information contained in this disclosure is correct and that I am duly authorised to make this

disclosure by all persons for whom it is made.

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.